Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 25, 2018

View Archived Issues

Nohla Therapeutics' NLA-101 receives orphan drug designation in E.U.

NIAID awards SBIR grant to support preclinical development of NovoBiotic's NOVO-29

Apexian Pharmaceuticals initiates phase I trial of APX-3330 in patients with solid tumors

FDA clears IND application for VY-AADC pivotal program in advanced Parkinson's disease

Anti-RGMA ameliorates symptoms of neuromyelitis optica

Santhera anticipates negative CHMP opinion on appeal for MAA for Raxone

IntelGenx studying Montelukast Versafilm in proof-of-concept trial in Alzheimer's

Activity seen with anti-PD-1 antibody JS-001 in advanced gastric adenocarcinoma

PF-05280586 demonstrates equivalence to MabThera in clinical trial

European Commission grants orphan drug designation to sirolimus for sickle cell disease

Treos Bio cleared by FDA to conduct phase I study of PolyPEPI-1018

Achieve Life Sciences amends technology license agreement with University of Bristol

TrovaGene begins phase II study of PCM-075 in mCRPC

M-7824 shows potential as therapy for heavily pretreated CRC patients

First pivotal trial of F-627 to treat chemotherapy-induced neutropenia meets primary endpoint

Iovance reports preliminary phase II data on autologous TIL therapy LN-145

Spark licenses voretigene neparvovec to Novartis outside U.S.

Translate Bio divulges mRNA compositions encoding ornithine transcarbamylase

Varian Medical Systems patents novel immune modulators

Genetically modified HUCPVCs created at Tissue Regeneration Therapeutics

Nitto Denko identifies novel inhibitors of GST class-pi and MRP-L17

Shanghai Institute of Cell Therapy and collaborators patent novel transgenic killer cells

Luye Pharma reports positive phase II results for LY-03005

Conditional approval for Vaccibody's CTA for phase I/II trial of VB10.NEO

European Commission grants approval to Taltz for active psoriatic arthritis

Synpromics collaborates with UCL to develop gene therapies for blood-based disorders

ACTR-087 studied in combination with SEA-BCMA in multiple myeloma